Back to Search
WILLIAM CARNEY, M.D.
M.D.
Family Medicine Physician
NPI: 1770521940IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine Physician
Emergency Medicine
Code: 207P00000X
34779(TN)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
34779(TN)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD34779(TN)
Education
UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Class of 1999
Research & Publications (20)
Predictors of shunt during carotid endarterectomy with routine electroencephalography monitoring.
PMID 19497494·J Vasc Surg·2009
8-other
Hidden HER-2/neu-positive breast cancer: how to maximize detection.
PMID 19350468·IDrugs·2009
6-review
Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer.
PMID 18661530·Cancer·2008
4-observational
Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer.
PMID 18443351·J Clin Oncol·2008
4-observational
Chronic hand ischemia treated with radial artery balloon angioplasty: case report.
PMID 18406959·J Hand Surg Am·2008
5-case
The effects of vasoactive agents on flow through saphenous vein grafts during lower-extremity peripheral vascular surgery.
PMID 17544884·J Cardiothorac Vasc Anesth·2007
2-rct
Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers.
PMID 17489737·Expert Rev Mol Diagn·2007
6-review
Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer.
PMID 17407159·Cancer·2007
3-trial
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer.
PMID 17048231·Cancer·2006
3-trial
Personal accounts: my experiences as a psychiatric patient in the 1960s.
PMID 16339611·Psychiatr Serv·2005
8-other
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy.
PMID 15952182·Cancer·2005
8-other
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.
PMID 15245613·Clin Breast Cancer·2004
6-review
The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.
PMID 15138574·Oncol Rep·2004
4-observational
Aortoiliac insufficiency: long-term experience with stent placement for treatment.
PMID 15068949·Radiology·2004
4-observational
Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer.
PMID 14500583·Clin Chem·2003
1-meta
Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen.
PMID 12743150·J Clin Oncol·2003
3-trial
Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.
PMID 12142389·Clin Chem·2002
3-trial
Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer.
PMID 11896093·J Clin Oncol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 175 Hospital Dr
Camden, TN 38320 - Phone
- (731) 213-2662
Quick Facts
- NPI
- 1770521940
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile